JSNM2021/JSNMT2021

Session information

[JSMN]

Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » JSNM Symposium

JSNM Symposium 9
Diagnosis and therapy of cardiac amyloidosis

Sat. Nov 6, 2021 8:30 AM - 10:00 AM Room2 (No.1 Building 4F 141+142)

Chair:Takashi Kudo(Department of Radioisotope Medicine, Atomic Bomb Disease Institute, Nagasaki University)、 Yasuyo Taniguchi(Hyogo Brain & Heart Center at Himeji)

Supported by Japanese Society of Nuclear Cardiology

Though the disease type of the cardiac amyloidosis is diversified, the transthyretin type (ATTR) amyloidosis has been noticed as a disease for which the health insurance treatment became possible recently. In particular, Tc-99m pyrophosphate scintigraphy is important in the differential diagnosis, and the heart-to-contralateral uptake ratio (H/CL ratio) is also frequently used. Four experts will be invited to discuss nuclear medicine diagnosis, multi-modality diagnosis and treatment of cardiac amyloidosis at this JSNM-JSNC symposium.